Investment Summary

Anzu Partners Invests In Partium

On November 10, 2020, growth capital firm Anzu Partners invested in software company Partium

Investment Highlights
  • This is Anzu Partners’ 2nd transaction in the Software sector.
  • This is Anzu Partners’ 20th transaction in the United States.
  • This is Anzu Partners’ 2nd transaction in Pennsylvania.

Investment Summary
Date 2020-11-10
Target Partium
Sector Software
Investor(s) Anzu Partners
Deal Type Venture

Target

Partium

Philadelphia, Pennsylvania, United States
Partium creates a lightning-fast, instant, and reliable search experience for everyone looking for spare parts. Partium is based in Philadelphia, Pennsylvania.

Search 202,137 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Anzu Partners

Investor Investor Investor Investor Investor

Category Growth Capital Firm
Founded 2014
PE ASSETS 1.0B USD
Size Middle-Market
Type Sector Agnostic
DESCRIPTION

Anzu Partners is a venture capital and private equity firm that looks to develop and commercialize technological advancements in manufacturing, materials, monitoring/measurement, and modeling. This includes 3D printing, robotics, nanotechnology, composites, sensors, AI, and analytics. Anzu Partners was formed in 2014 and is headquartered in Boston, Massachusetts.

DEAL STATS #
Overall 23 of 35
Sector (Software) 2 of 3
Type (Venture) 22 of 32
State (Pennsylvania) 2 of 2
Country (United States) 20 of 29
Year (2020) 9 of 9
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-09-02 Aspinity

Pittsburgh, Pennsylvania, United States

Aspinity engages in design and development of analog machine learning chips that are revolutionizing the architecture of always-on sensing devices that run on battery. Aspinity was founded in 2015 and is based in Pittsburgh, Pennsylvania.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-02-17 Excision BioTherapeutics

San Francisco, California, United States

Excision BioTherapeutics is a biotechnology company developing CRISPR-based therapies to cure viral infection diseases and improve the lives of chronically ill patients. Excision BioTherapeutics is based in San Francisco, California.

Buy -
Mergr

Product

Company

Legal